Q87RW0 AF NFT

Phosphoribosylformylglycinamidine synthase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeicpcpa5l5egeum4bwvv32enloc64xvbp5soqtojcb3szif6venxdq/metadata.json
IPFS of structure file: 
bafybeigqit6l5jcskeqlcskyy5cvxb72ynmtz2lryuu3jmmrobls5bggtu/AF-Q87RW0-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xC247c99E05131ed14368eDD5e659B4F41aFA32ab
First NFT owner address (bech32): 
genesis1cfrun8s9zv0dzsmgah27vkd57sd05v4tfrx52v
Current NFT ID #320645 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1_w

NFT id:
320645
Accession (UniProt):
Q87RW0
Name::
Phosphoribosylformylglycinamidine synthase
Experimental Method:
Predicted structure
Sequence source:
VIBRIO PARAHAEMOLYTICUS SEROTYPE O3:K6 (STRAIN RIMD 2210633)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q87RW0 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q87RW0|PUR4_VIBPA Phosphoribosylformylglycinamidine synthase OS=Vibrio parahaemolyticus serotype O3:K6 (strain RIMD 2210633) OX=223926 GN=purL PE=3 SV=1 MRILRGSPALSEFRVNKLLELCREQDLPVTGIYAEFMHFADLKSDLDDQELEKLEKLLTYGPTIEEHEPEGLLLLVTPRPGTISPWSSKSTDIAINCGLDTVKRLERGTAYYVESSVVLSEAQVDAVKALIHDRMMETVFTELEAASALFTVAEPKPVAHVDILAGGRLALEEANVSLGLALAEDEIDYLVENFTKLGRNPNDIELMMFAQANSEHCRHKIFNADWTIDGVDQEKSLFKMIKNTFETTPDHVLSAYKDNAAVMTGSKVGRFFPDPKSRQYTYHHEDAHILMKVETHNHPTAISPWPGASTGSGGEIRDEGATGIGGKPKAGLVGFTTSNLRIPGFEQPWETDFGKPGRIVNALDIMLEGPLGGAAFNNEFGRPNLLGYFRTYEEKVTSHAGEEVRGYHKPIMIAGGMGNIRDEHVQKKEIPVGASLIVLGGPAMNIGLGGGAASSMASGQSAEDLDFASVQRENPEMERRCQEVIDRCWQLGEENPIAFIHDVGAGGISNALPELCDDGERGGKFQLRDVPNDELSMSPLEIWCNESQERYVLAVAPENMEAFDAICKRERAPYAVVGVATEERHLTLEDSHFDNTPIDMPMDILLGKTPKMHREATTLKVDSPAIARDGIEIDEAADRVLRLPTVAEKTFLITIGDRSVTGLVARDQMVGPWQVPVANCAVTAASYDTYHGEAMSMGERTPVALLDFGASARLAVGESLTNIAATDIGDIKRIKLSANWMSPAGHPGEDAGLYEAVKAVGEELCPALGLTIPVGKDSMSMKTKWEENGESKEVTSPLSLVITAFGRVEDVRKTVTPQLRTSDTLEGLGDTSLVLVDLGNGKNRLGATALAQVYKQLGDKPADVDNAEQLKGFFDAMQNLVRNDKLLAYHDKGDGGLFVTLAEMAFAGHCGVKADIAELGEDALAVLFNEELGAVVQVKNDDLDSVLSTLAANGLEACSHVIGSVEASDDFVFTSGDDVVLKRSRTELRVIWAETTHKMQALRDNPACADQEFEAKKDNTDPGLNVSLSFDVNEDIAAPYIAKGAKPKMAILREQGVNSHVEMAAAFDRAGFEATDIHMSDILTGQAVLDEYQGLVACGGFSYGDVLGAGEGWAKSILFNAQAREQFQAFFNREETFSLGVCNGCQMLSNLKELIPGADLWPRFVRNESERFEARFSLVEVQKSDSVFFDGMAGSRMPIAVSHGEGRVEVRDGEHLNAIEASGTVALRYVDNNGNPTQQYPNNPNGSPNAITGLTTADGRVTIMMPHPERVFRTVANSWAPEGWGENGAWMRMFQNARKNIG